Fibrotic Burden Determines Cardiovascular Risk among Subjects with Metabolic Dysfunction-Associated Fatty Liver Disease

BACKGROUND/AIMS: Metabolic dysfunction associated fatty liver disease (MAFLD) has recently been introduced to compensate for the conventional concept of nonalcoholic fatty liver disease (NAFLD). We explored whether fibrotic burden determines the risk of atherosclerotic cardiovascular disease (ASCVD)...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Eugene, Lee, Yong-ho, Lee, Jae Seung, Lee, Hye Won, Kim, Beom Kyung, Park, Jun Yong, Kim, Do Young, Ahn, Sang Hoon, Lee, Byung-Wan, Kang, Eun Seok, Cha, Bong-Soo, Kim, Seung Up
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of Gut and Liver 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9474484/
https://www.ncbi.nlm.nih.gov/pubmed/35321955
http://dx.doi.org/10.5009/gnl210290

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9474484/
https://www.ncbi.nlm.nih.gov/pubmed/35321955
http://dx.doi.org/10.5009/gnl210290

Ejemplares similares